Creutzfeldt-Jakob disease treated with amantidine: A report of two cases
Open Access
- 1 August 1973
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 36 (4) , 581-584
- https://doi.org/10.1136/jnnp.36.4.581
Abstract
The treatment of two cases of Creutzfeldt-Jakob disease with amantidine is described. The first case made a remarkable initial improvement which was sustained for two months, but then deteriorated and died. Histological examination of the brain showed changes consistent with early Creutzfeldt-Jakob disease. The second case which was clinically one of Creutzfeldt-Jakob disease has now been followed for 30 months since the start of treatment and appears to be cured. It is considered that amantidine has a definite effect in this disease and it is suggested that its mode of action, though unknown, is more likely to be metabolic than antiviral.Keywords
This publication has 6 references indexed in Scilit:
- Jakob-Creutzfeldt disease: treatment by amantadine.BMJ, 1971
- THERAPEUTIC EFFECT OF 1-ADAMANTANAMINE HYDROCHLORIDE IN NATURALLY OCCURRING INFLUENZA A2/HONG KONG INFECTION: A Controlled Double-blind StudyPublished by Elsevier ,1971
- TREATMENT OF PARKINSON'S DISEASE WITH AMANTADINE AND LEVODOPA: A One-year StudyThe Lancet, 1971
- Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the ChimpanzeeScience, 1968
- CREUTZFELDT-JAKOB DISEASE; 1. Survey of The Literature and Clinical DiagnosisActa Neurologica Scandinavica, 1968
- On Some Aspects of Cerebral Degeneration in Later LifeProceedings of the Royal Society of Medicine, 1967